• No results found

[PDF] Top 20 FORMULATION, DEVELOPMENT AND EVALUATION OF BI-LAYER TABLET OF ANTI HIV DRUG

Has 10000 "FORMULATION, DEVELOPMENT AND EVALUATION OF BI-LAYER TABLET OF ANTI HIV DRUG" found on our website. Below are the top 20 most common "FORMULATION, DEVELOPMENT AND EVALUATION OF BI-LAYER TABLET OF ANTI HIV DRUG".

FORMULATION, DEVELOPMENT AND EVALUATION OF BI-LAYER TABLET OF ANTI HIV DRUG

FORMULATION, DEVELOPMENT AND EVALUATION OF BI-LAYER TABLET OF ANTI HIV DRUG

... the drug, polymer and other excipients selected were passed through 40-mesh ...of drug, polymer and excipients were weighed properly and transferred into polyethylene bag and the blend was mixed for at ... See full document

7

FORMULATION AND EVALUATION OF BILAYER FLOATING TABLETS OF BETAHISTINE HYDROCHLORIDE

FORMULATION AND EVALUATION OF BILAYER FLOATING TABLETS OF BETAHISTINE HYDROCHLORIDE

... to formulation and development of oral pharmaceutical bilayer tablet of betahistine HCl for administration of therapeutically and prophylactically effective amount of antihistaminic drug ... See full document

10

FORMULATION AND EVALUATION OF BI LAYER DOMPERIDONE FLOATING TABLETS

FORMULATION AND EVALUATION OF BI LAYER DOMPERIDONE FLOATING TABLETS

... developing bi-layer tablets currently variety of reasons: patent extension, therapeutic, marketing to name a ...modified tablet presses are used to develop and produce such ...the development ... See full document

9

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF DOUBLE LAYER TABLET OF SUSTAINED RELEASE (S R ) FLURBIPROFEN AND IMMEDIATE RELEASE DOXYCYCLINE

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF DOUBLE LAYER TABLET OF SUSTAINED RELEASE (S R ) FLURBIPROFEN AND IMMEDIATE RELEASE DOXYCYCLINE

... the bi-layer tablet of doxycycline immediate release and flurbiprofen sustained ...Method: Bi-layer tablets were formulated by wet granulation ...excipients. Bi-layer ... See full document

8

DESIGN AND IN VITRO EVALUATION OF BILAYER TABLET CONTAINING TWO INCOMPATIBLE ANTIHYPERTENSIVE DRUGS

DESIGN AND IN VITRO EVALUATION OF BILAYER TABLET CONTAINING TWO INCOMPATIBLE ANTIHYPERTENSIVE DRUGS

... develop tablet formulation for two incompatible antihypertensive drugs Amlodipine besilate and Losartan potassium as an immediate release bi layer tablet and to evaluate its dissolution ... See full document

11

FORMULATION DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF LIQUISOLID TABLET CONTAINING PIOGLITAZONE HCL

FORMULATION DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF LIQUISOLID TABLET CONTAINING PIOGLITAZONE HCL

... the drug into the propylene glycol, which in terms increase the wetting property and surface area of drug particle and hence improve the dissolution and oral bioavailibity of the ...the drug and ... See full document

9

Formulation development and evaluation of smart polymer gel formulation for ophthalmic drug delivery

Formulation development and evaluation of smart polymer gel formulation for ophthalmic drug delivery

... between drug and ...vitro drug release study of all the formulations, selected formulations ...Thin layer chromatography was carried out to check the drug polymer interaction after autoclaving ... See full document

8

FORMULATION DEVELOPMENT AND EVALUATION OF GASTRO RETENTIVE FLOATING TABLET OF ATORVASTATIN USING STATISTICAL DESIGN (JMP SOFTWARE)

FORMULATION DEVELOPMENT AND EVALUATION OF GASTRO RETENTIVE FLOATING TABLET OF ATORVASTATIN USING STATISTICAL DESIGN (JMP SOFTWARE)

... and drug Atorvastatin ...rotary tablet processing machine. Each formulation was composed of drug and excipients in various proportions as shown in Table1 and Table 2: ... See full document

7

COMPATIBILITY OF ANTI-HIV DRUGS WITH EXCIPIENTS IN THE DEVELOPMENT OF NOVEL TABLET FORMULATION

COMPATIBILITY OF ANTI-HIV DRUGS WITH EXCIPIENTS IN THE DEVELOPMENT OF NOVEL TABLET FORMULATION

... different anti-HIV drug with ...various tablet formulations of anti-HIV drugs can be developed which can be used the production of commercial tablet batch of the ...of ... See full document

7

FORMULATION AND EVALUATION OF BIOADHESIVE MATRIX TABLET OF AN ANTIFUNGAL DRUG

FORMULATION AND EVALUATION OF BIOADHESIVE MATRIX TABLET OF AN ANTIFUNGAL DRUG

... the formulation of bioadhesive tablets due to it‟s fewer formulation steps, less chance of contamination or cross contamination and easiness to meet the requirements of current good manufacturing ...all ... See full document

26

Formulation, Optimization and Evaluation of Bilayer Tablet of Antihypertensive Drug

Formulation, Optimization and Evaluation of Bilayer Tablet of Antihypertensive Drug

... Friability generally refers to loss in weight of tablets in the containers due to removal of fines from the tablet surface. Friability generally reflects poor cohesion of tablet ingredients. 10 tablets were ... See full document

5

FORMULATION AND EVALUATION OF BILAYERED FLOATING TABLET OF DILTIAZEM DRUG

FORMULATION AND EVALUATION OF BILAYERED FLOATING TABLET OF DILTIAZEM DRUG

... Bilayer tablet is new era for developing a combination of two or more active pharmaceutical ingredient in single dosage form, Promoting patient convenience and ...release tablet is a unit compressed ... See full document

5

FORMULATION AND EVALUATION OF HERBAL TABLET CONTAINING METHANOLIC EXTRACT OF CALOPHYLLUM INOPHYLLUM

FORMULATION AND EVALUATION OF HERBAL TABLET CONTAINING METHANOLIC EXTRACT OF CALOPHYLLUM INOPHYLLUM

... the formulation preparation, the chloroform and methanol extracts of Calophyllum inophyllum stem barks were evaluated for their analgesic and anti-inflammatory activity studies by using different animal ... See full document

6

Preparation and Evaluation of Bi-layer Floating Tablet of ydrochlorothiazide and Propranolol HCl

Preparation and Evaluation of Bi-layer Floating Tablet of ydrochlorothiazide and Propranolol HCl

... the drug from the matrix system was decreased ...that formulation F6, containing 80mg of HPMC polymer in formulation was able to produce desire formulation which released ... See full document

7

 FORMULATION DEVELOPMENT AND EVALUATION OF CARVEDILOL TABLET

 FORMULATION DEVELOPMENT AND EVALUATION OF CARVEDILOL TABLET

... the drug with its physical and chemical properties and the preferred drug dose in the tablet, find the 12 excipients and their amounts, when mixed they can be compressed into a tablet ... See full document

5

Formulation Development & Evaluation of Buffered Tablet of Proton Pump Inhibitors Drug Rabeprazole Sodium

Formulation Development & Evaluation of Buffered Tablet of Proton Pump Inhibitors Drug Rabeprazole Sodium

... of drug and selected ingredients was observed that all characteristic peaks of rabeprazole were present in the combination spectrum, thus indicating compatibility between drug and selected ... See full document

7

Formulation and in-vitroevaluation of gastro retaintive bi-layered floating tablet of sucralfate and metoprolol succinate

Formulation and in-vitroevaluation of gastro retaintive bi-layered floating tablet of sucralfate and metoprolol succinate

... Release Layer and 286mg of antihypertensive Metoprolol Succinate as Floating Sustained Release ...pre formulation study , in vitro evaluation, accelerated stability ...Then Bi Layered Floating ... See full document

7

Formulation development of bi layer acetaminophen tablets for extended drug release

Formulation development of bi layer acetaminophen tablets for extended drug release

... Study was carried out by using infrared spectrophotometer to find out if there is any possible chemical interaction of acetaminophen with micro crystalline cellulose, HPMC, aerosil 200, sodium starch glycolate and ... See full document

13

FORMULATION AND EVALUATION OF SUCRALFATE AND METOPROLOL SUCCINATE BI-LAYER FLOATING TABLET AS GASTRO RETENTIVE DRUG DELIVERY SYSTEM

FORMULATION AND EVALUATION OF SUCRALFATE AND METOPROLOL SUCCINATE BI-LAYER FLOATING TABLET AS GASTRO RETENTIVE DRUG DELIVERY SYSTEM

... of drug in the matrix, k0 the zero order kinetic constant, k1 the first order kinetic constant and kH representing the Higuchi rate ...percent drug released aszero order, Time versus cumulative percent ... See full document

18

SOLUBILITY ENHANCEMENT, FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLET OF ANTIHYPERTENSIVE DRUG TADALAFIL

SOLUBILITY ENHANCEMENT, FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLET OF ANTIHYPERTENSIVE DRUG TADALAFIL

... bioavailability. Formulation and evaluation of immediate release tablets prepare from solubility enhanced ...release tablet and evaluated for the interactions and in vitro drug ...overall ... See full document

9

Show all 10000 documents...